Navigation Links
AMDL, Inc. Announces First Quarter 2009 Financial Results
Date:5/15/2009

ertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL, Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.


'/>"/>
SOURCE AMDL, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related medicine news :

1. AMDL, Inc. Selected as #1 Small-Cap Stock Pick for 2009
2. Rudd Report Gives AMDL, Inc. a Strong Buy Recommendation in Year-End Financial Research Report
3. AMDL, Inc. Completes Revision of Performance & Equity Incentive Compensation Plan
4. AMDL, Inc. Chairman & CEO Announces Expert Opinion on Chinas Economic Forecast
5. AMDL, Inc. Announces Final Closing of Private Placement of Senior Notes
6. AMDL, Inc. Issues Correction to January 30, 2009 Press Release Announcing Closing of Private Placement of Senior Notes
7. AMDL, Inc. to Present at 5th Annual Winter Technology Conference Hosted by Security Research Associates, Inc.
8. AMDL, Inc. Reports 2008 Year End Financial Results and Fiscal Year 2009 Financial Targets
9. AMDL, Inc. Enters Into Distribution Agreements With GenWay Biotech, Inc. to Advance Commercialization of the DR-70 (FDP) Cancer Test in the US and Canada
10. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
11. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)NEW YORK, Dec. 4 Thousands of KPMG LLP employees came together in more than 90 offices nationwide today, to participate in a community service event which combines the audit, tax and advisory firm,s
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3
... composed of polymer layers and nanoparticles may ...without harming the rest of the body, according to...m could be robust and flexible enough to deliver a...te student, chemical engineering. "The drugs are p...
...ickly becoming the "it" nutrient with health benef...heart disease and now diabetes. , A recent revi...iversity Chicago Marcella Niehoff School of Nursin...nosed. These findings appeared in the latest issu...
...rsity of Arizona are developing a set of standardi...ith Down syndrome. , The condition, which occurs...ths, is signaled by the presence of an extra 21st ...early onset of Alzheimer,s dementia. New research ...
... be paid after hospital discharge, , , MON...the veterans treated in Veterans Affairs hospitals...ter risk of suicide than non-depressed veterans, ...esearchers wondered? , Their five-year study of v...
...l Year 2008 Earnings Conference Call , Thursday, F...ZER, Pa., Jan. 12 Cephalon, Inc . (Nasdaq: CEP...onference call covering fourth quarter and full ye... will be distributed by PRNewswire , 4:50 p.m. EST...
...a worthy cause at Access Hollywood,s 3rd Annual "S...Lollipop Theater Network. , , LOS ANGELES, Jan. 1..., once again donated $100,000 to two important cha...onsecutive beauty sponsorship of the lounge, which...
Other Medicine News:Health News:Tiny capsules deliver 2Health News:Vitamin D is the 'it' nutrient of the moment 2Health News:Standardized test battery to aid those with Down syndrome 2Health News:Standardized test battery to aid those with Down syndrome 3Health News:Standardized test battery to aid those with Down syndrome 4Health News:Standardized test battery to aid those with Down syndrome 5Health News:Standardized test battery to aid those with Down syndrome 6Health News:With Depression, Vets Face Higher Suicide Risk 2Health News:With Depression, Vets Face Higher Suicide Risk 3Health News:CVS/pharmacy Teams Up with Access Hollywood for an Award Season Gifting Suite That Gives Back 2Health News:CVS/pharmacy Teams Up with Access Hollywood for an Award Season Gifting Suite That Gives Back 3
(Date:12/3/2009)MADISON, N.J., Dec. 3 A genetic variation that may indicate a patient,s risk of developing a potentially life-threatening blood disorder if exposed to certain pharmaceutical therapies or chemicals is
(Date:12/3/2009)SAN DIEGO, Dec. 3 BioMed Realty Trust, Inc. (NYSE: BMR ) announced today that it has entered into a new lease with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) for approximately 131,000 square
(Date:12/3/2009)HOERSHOLM, Denmark and SAN DIEGO, California, December 3 , - SPC3649 Successfully Inhibits miR-122, a microRNA Important for,Hepatitis C Viral Replication, Thereby Significantly Reducing Hepatiti
Breaking Medicine Technology:Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 2Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition 3BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 2BioMed Realty Trust Signs New Lease With Regeneron Pharmaceuticals for 131,000 Square Feet at Landmark 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 1Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 2Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 3Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 4Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 5Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 6Caraco Pharmaceutical Laboratories Ltd Reports Results for the First Quarter of Fiscal Year 2010 52994 7Stent Studies Tied to Rapid Changes in Use 52992 1Stent Studies Tied to Rapid Changes in Use 52992 2DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 1DURECT to Present at the BMO Capital Markets Healthcare Conference 52990 2
...s,Inc. (Amex: IMM ) is pleased to announce today ...h as a strategic advisor. General Clark will,provi...pany develops its,drug programs targeting various ...tion and treatment. General Clark is one of the c...ers and a respected international voice in public ...
...ry biliary cirrhosis patient,has the biomarker of ...nic,researchers have found that first-degree relat...s with primary biliary cirrhosis (PBC) are,more li... blood. Armed with,this new information, physician...f PBC patients with a simple blood test, enabling ...
Other Medicine Technology:General Wesley Clark Joins Immtech as Consulting Strategic Advisor 2General Wesley Clark Joins Immtech as Consulting Strategic Advisor 3New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families 2
Fibrinogen Control
MONO Mononucleosis Rapid Test Device
...Z Flu A+B test is a rapid chromatographic immunoas...fluenza A and B viral antigens from nasopharyngeal...patients. The Directigen EZ Flu A+B test is a diff...ens can be distinguished from influenza B viral an...
..., the Jarvik 2000 pump is about the size of a C ba...ect-current motor, a rotor supported by two cerami...nning titanium impeller that pumps blood from the ...ke over for the biological heart, the Jarvik 2000 ...
Medicine Products: